Omnicell (OMCL) Notes Payables (2021 - 2025)
Omnicell (OMCL) reported Notes Payables of $174.8 million for Q2 2025, little changed quarter-over-quarter from $174.6 million in Q1 2025.
Omnicell (OMCL) Notes Payables (2021 - 2025) Analysis & Trends
Omnicell (OMCL) has 4 years of Notes Payables data on file, last reported at $174.8 million in Q2 2025.
- Notes Payables for Q2 2025 came in at $174.8 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $174.8 million (changed N/A YoY), and the FY2024 annual result was $174.3 million, changed N/A from the prior year.
- Notes Payables was little changed at $174.8 million in Q2 2025 per OMCL's latest filing, from $174.6 million in the prior quarter.
- Over five years, Notes Payables peaked at $572.0 million in Q3 2024 and troughed at $174.3 million in Q4 2024.
- A 4-year average of $358.0 million and a median of $331.5 million in 2021 frame the typical range for Notes Payables.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Teladoc Health | 1.45 Bn | 696.57 Mn | 562.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 174.80 Mn |
| Mar 31, 2025 | 174.56 Mn |
| Dec 31, 2024 | 174.32 Mn |
| Sep 30, 2024 | 572.00 Mn |
| Mar 31, 2022 | 564.27 Mn |
| Dec 31, 2021 | 488.15 Mn |